United States v. Semitra Young , 682 F. App'x 420 ( 2017 )


Menu:
  •                     NOT RECOMMENDED FOR FULL-TEXT PUBLICATION
    File Name: 17a0160n.06
    No. 16-5360
    UNITED STATES COURT OF APPEALS
    FOR THE SIXTH CIRCUIT                                FILED
    Mar 14, 2017
    UNITED STATES OF AMERICA,                                )                   DEBORAH S. HUNT, Clerk
    )
    Plaintiff-Appellee,                            )
    )
    ON APPEAL FROM THE
    v.                                                       )
    UNITED STATES DISTRICT
    )
    COURT FOR THE WESTERN
    SEMITRA YOUNG,                                           )
    DISTRICT OF TENNESSEE
    )
    Defendant-Appellant.                           )
    Before: MERRITT, KETHLEDGE, and WHITE, Circuit Judges.
    KETHLEDGE, Circuit Judge. Semitra Young appeals her sentence for conspiracy to
    distribute oxycodone and hydrocodone in violation of 21 U.S.C. §§ 841 and 846. Young argues
    that her sentence was procedurally and substantively unreasonable. We reject her arguments and
    affirm.
    I.
    Young started using Lortab, a hydrocodone-based opioid, under a doctor’s supervision in
    2008. By 2011, Young was addicted, taking ten to fifteen Lortab pills a day. When her doctor
    refused to refill her prescription, Young looked for other ways to get drugs. She started small,
    forging a single prescription for oxycodone, another opioid painkiller.       But soon she was
    engaged in a criminal conspiracy involving thousands of pills from pharmacies across several
    states.
    No. 16-5360, United States v. Young
    In March 2012, police in Southaven, Mississippi arrested Young and another person after
    they tried to fill a fraudulent prescription for Roxicodone, an oxycodone-based painkiller. When
    the police searched Young’s car, they found fraudulent prescriptions for 1500 pills: 720 Lortab,
    600 Roxicodone, and 180 Xanax, an alprazolam-based drug for anxiety. They also found a .380
    caliber pistol, and several marijuana cigarettes. The officers then searched Young’s hotel room,
    where they found more fraudulent prescriptions, this time for 1,680 Lortab, 640 Roxicodone, and
    90 Xanax pills. They also found materials for making and forging prescriptions, including blank
    prescription papers; a computer, printer, label maker, and paper cutter; and notebooks containing
    doctors’ DEA numbers, which are identification numbers that allow registered health-care
    providers to write prescriptions for narcotics.
    Three months later, police in Memphis stopped Young and searched her car. Inside her
    purse, the police found 58 Xanax pills which, according to the label on the bottle, had been
    prescribed to someone other than Young. The police also found several loose Xanax pills, a
    hydrocodone pill, several fraudulent prescriptions, and blank prescription papers.
    Another three months later, in September 2012, Memphis police stopped Young again.
    This time, they found a loose hydrocodone pill and an empty bottle of oxycodone, which again
    was prescribed to someone other than Young. The police also found fraudulent prescriptions for
    240 Roxicodone and 480 pills of Percocet—another oxycodone-based opioid—along with
    notebooks containing information about the fraudulent prescriptions, and several blank
    prescriptions made out in different names.
    In February 2013, Memphis police stopped Young for a third time, searched her car, and
    found fraudulent prescriptions for 840 Lortab, 360 Roxicodone, and 120 Xanax pills.
    -2-
    No. 16-5360, United States v. Young
    In early June 2013, Young and another person made two unsuccessful attempts at filling
    fraudulent prescriptions in Tennessee and Arkansas. Later that month, Memphis police stopped
    Young for a fourth time. When they searched her car, they found fraudulent prescriptions for
    360 Lortab, 480 Roxicodone, and 360 Xanax pills.
    The police eventually determined that Young was part of a drug conspiracy, in which she
    paid three people to help her fill fraudulent prescriptions, and then sold some of the drugs to
    another dealer. Young’s method was as follows: first, she bought somewhere between 500 and
    1,000 sheets of blank prescription paper; then she made fake prescriptions with the fraudulently-
    obtained DEA numbers, as well as a phone number she controlled. If a pharmacy called to
    inquire about a prescription, Young or a co-conspirator would answer and pretend to be from a
    legitimate doctor’s office.
    In December 2014, the government charged Young with conspiracy to distribute, and
    possess with intent to distribute, oxycodone and hydrocodone, in violation of 21 U.S.C.
    §§ 841(b)(1)(c) and 846. Young pled guilty.
    The presentence investigation report estimated that Young was responsible for 6,300
    oxycodone, 9,400 hydrocodone, and 820 Xanax pills, which were for sentencing purposes the
    cumulative equivalent of 1275.75125 kilograms of marijuana. The report recommended upward
    adjustments for Young’s leadership role and possession of a firearm, and a downward adjustment
    for acceptance of responsibility, resulting in a total offense level of 33. The corresponding
    sentencing guidelines range was 135 to 168 months.
    Young objected to the presentence report. She argued that she should not be punished for
    prescriptions that she had written but not yet filled, nor for drugs she had kept for personal use.
    -3-
    No. 16-5360, United States v. Young
    Young also argued that her drug addiction, and the harshness of the oxycodone guidelines,
    warranted a below-guidelines sentence.
    At Young’s sentencing hearing, the district court rejected her arguments and sentenced
    her to 105 months’ imprisonment—the low end of the guidelines range, less 30 months for time
    served on related state-law charges. This appeal followed.
    II.
    We review Young’s sentence for an abuse of discretion. United States v. Coppenger, 
    775 F.3d 799
    , 802 (6th Cir. 2015).
    A.
    Young argues that her sentence is procedurally unreasonable. A court errs procedurally if
    it calculates a sentencing guidelines range incorrectly. Gall v. United States, 
    552 U.S. 38
    , 51
    (2007). In a drug case, a guidelines range is incorrect if the court is wrong about the quantity of
    drugs for which the defendant is responsible. United States v. Jeross, 
    521 F.3d 562
    , 569-70 (6th
    Cir. 2008). Young contends that the court was wrong here because, when it found the quantity
    of drugs for which she was responsible, it included prescriptions that she had written but not yet
    filled.
    The court may count drugs that a defendant intended to obtain, and would have obtained,
    but for logistical obstacles. See United States v. Vasquez, 
    560 F.3d 461
    , 472 (6th Cir. 2009).
    And the quantity of drugs for which a defendant may be held responsible is not limited to drugs
    that the police actually seize. See 
    id. Here, the
    unfilled prescriptions that the court counted towards Young’s drug quantity
    were prescriptions ready to be delivered to a pharmacy: they listed drug names and quantities,
    and doctors’ names and DEA numbers. Young does not dispute that she filled or attempted to
    -4-
    No. 16-5360, United States v. Young
    fill many similar prescriptions. The evidence thus suggests that Young intended to obtain drugs
    with the prescriptions, and would have done so had she not been arrested. The court did not err
    by including the unfilled prescriptions in the calculation of her sentencing guideline range.
    Young responds by citing several cases where unfilled prescriptions were excluded from
    sentencing calculations. See, e.g., United States v. Rodriguez-Iznaga, 575 F. App’x 583, 587
    (6th Cir. 2014). But those cases involved potentially legitimate prescriptions written by medical
    professionals. Here, none of the unfilled prescriptions were legitimate and the cases Young cites
    are therefore inapposite.
    Young also contends that the court should not have counted drugs that she planned to use
    herself.     In a drug conspiracy, however, drugs intended for personal use are counted for
    sentencing purposes. United States v. Page, 
    232 F.3d 536
    , 542 (6th Cir. 2000). Thus, the court
    did not err when calculating the drug quantity. Young’s sentence was procedurally reasonable.
    B.
    Young also challenges the substantive reasonableness of her sentence, arguing that the
    court should have given her a sentence below the guidelines range.            Specifically, Young
    contends that the court should have departed downward because she is a drug addict, and
    because the oxycodone-to-marijuana conversion ratio is unduly harsh. A district court may
    depart from the sentencing guidelines range, but it is not obliged to do so. United States v.
    Brooks, 
    628 F.3d 791
    , 800 (6th Cir. 2011). And a within-guidelines sentence is presumptively
    reasonable. United States v. Kamper, 
    748 F.3d 728
    , 739-740 (6th Cir. 2014).
    Here, the court considered Young’s personal history and drug addiction, but ultimately
    determined that Young’s repeated opportunities to end the conspiracy, and her leadership role in
    a complex criminal scheme, called for a within-guidelines sentence.           Likewise, the court
    -5-
    No. 16-5360, United States v. Young
    considered Young’s argument about the oxycodone-to-marijuana ratio, but concluded that the
    known dangers of oxycodone warranted a within-guidelines sentence.       The district court
    therefore did not abuse its discretion, and Young’s challenge to her sentence’s substantive
    reasonableness fails.
    *       *    *
    The district court’s judgment is affirmed.
    -6-